AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
Sinusitis can be acute, lasting less than four weeks, or chronic, lasting longer for months despite treatment. Symptoms of sinusitis include: While sinusitis can be uncomfortable and disruptive, there ...
In our study, the incidence of asthma among patients with chronic rhinosinusitis without nasal polyps was 23.8%, which differs from the findings of some previous studies. This discrepancy may be ...
Sinus infections can indeed be troubling and disruptive, resulting in symptoms such as headaches, congestion and discomfort in the face that can hinder your everyday activities. Although several ...
Chronic kidney failure ... will diagnose you with kidney failure if your eGFR is 15 or less for three months or more. Urine tests are valuable tools in diagnosing kidney failure.
The Bureau of Meteorology (BOM) has released its longer range weather outlook for the next three months into the New Year. It comes as the expected La Nina climate driver, which increases the ...
This is particularly true for chronic diseases. For example, diabetes mellitus is defined biochemically according to the blood sugar concentration, cancer histologically according to the morphological ...
If you can’t avoid them altogether, there are several ways to deal with a chronic complainer. While everyone is negative sometimes, the constant pessimism from a chronic complainer can start ...
Malacia has not played since May 2023 (Picture: Manchester United via Getty Images) Tyrell Malacia is ‘very close’ to making his return for Manchester United after almost 18 months on the ...
If action isn't taken now, Ontario's hospital system will not be able to cope with the influx of chronic illness cases in the next two decades, Anthony Dale, OHA president, told CBC Toronto.
BEIJING, Oct 15 (Reuters) - China's exports to Russia grew 15.7% in September from a year earlier, the fastest pace in nine months and up from a 10.1% gain a month prior, Chinese customs data ...
(IN BRIEF) GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The trials demonstrated ...